Latest / Health News Today | 2 Min News | The Daily News Now!
Genetic Clues to Targeted CLL Treatments | Health and Fitness News
When treating chronic lymphocytic leukemia, doctors don’t just rely on the diagnosis—they decode the cancer’s genetic blueprint to predict behavior and tailor treatments. Key biomarkers like IGHV mutation status, chromosome abnormalities, and TP53 mutations reveal whether the cancer is slow or aggressive, guiding decisions toward targeted therapies like BTK inhibitors or venetoclax instead of outdated chemo. Since CLL’s genetics can evolve over time, these tests are repeated at diagnosis and before treatment to ensure the plan stays precise and effective. Listen in comfort:Get a discount on a…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.